Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cryo Cell International (CCEL) FCF Margin (2016 - 2025)

Cryo Cell International (CCEL) has disclosed FCF Margin for 16 consecutive years, with 15.47% as the latest value for Q4 2025.

  • On a quarterly basis, FCF Margin fell 1130.0% to 15.47% in Q4 2025 year-over-year; TTM through Nov 2025 was 16.63%, a 535.0% increase, with the full-year FY2025 number at 16.63%, up 535.0% from a year prior.
  • FCF Margin was 15.47% for Q4 2025 at Cryo Cell International, down from 31.92% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 38.63% in Q1 2021 to a low of 111.31% in Q3 2022.
  • A 5-year average of 8.87% and a median of 15.84% in 2025 define the central range for FCF Margin.
  • Peak YoY movement for FCF Margin: crashed -11835bps in 2022, then soared 9418bps in 2023.
  • Cryo Cell International's FCF Margin stood at 18.97% in 2021, then surged by 67bps to 31.62% in 2022, then crashed by -35bps to 20.69% in 2023, then rose by 29bps to 26.78% in 2024, then tumbled by -42bps to 15.47% in 2025.
  • Per Business Quant, the three most recent readings for CCEL's FCF Margin are 15.47% (Q4 2025), 31.92% (Q3 2025), and 8.13% (Q2 2025).